Inovio Pharmaceuticals Inc. Stock Rallies 4.3%, Outperforms Peers
Dow Jones2026/10/28 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. advanced 4.3% to $0.93 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.3% to 26,549.85 and the Dow Jones Industrial Average rising 0.2% to 52,475.10.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 65.9% below its 52-week high of $2.72, which the company reached on December 17th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $271.04, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 1.17% to $29.45.
Trading volume totaled 4.5 million, compared to the 50-day average of 3.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 28, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
